Ventyx Biosciences
Runkai Li currently serves as Senior Director and Head of Analytical Development and QC at Ventyx Biosciences. Prior experience includes roles as Director of CMC Analytical Development and QC at Bristol Myers Squibb and Director of CMC at Mirati Therapeutics. Runkai Li also held the positions of Sr. Principal Scientist (Analytical Technical Lead, CMC) and Sr. Principal Scientist (Analytical CMC) at Bristol Myers Squibb and Celgene, respectively.
This person is not in any teams
This person is not in any offices
Ventyx Biosciences
1 followers
Ventyx Biosciences is a biotechnology company with a diverse portfolio of best-in-class highly differentiated clinical and pre-clinical stage programs focused on high-value targets. Ventyx now includes combined assets from three separate companies: Oppilan Pharma, targeting S1P1R, Zomagen Biosciences, targeting NLRP3 and the inflammasome, and Ventyx Biosciences, targeting TYK2.